Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 13, 503-506, July 1, 1953]
© 1953 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geyer, R. P.
Right arrow Articles by Stare, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geyer, R. P.
Right arrow Articles by Stare, F. J.

Effect of Dose and Hormones on Tumor Production in Rats Given Emulsified 9,10-Dimethyl-1,2-benzanthracene Intravenously*

Robert P. Geyer, Jean E. Bryant, Virgil R. Bleisch, Elizabeth M. Peirce and Fredrick J. Stare

( Department of Nutrition, Harvard School of Public Health, Boston 15, Mass.)

Tumor production in female rats by means of intravenously administered 9,10-dimethyl-1,2-benzanthracene (DMBA) has been further studied from the standpoint of the dose of carcinogen given and the influence of simultaneously administered {alpha}-estradiol or diethylstilbestrol. Administration of approximately 5.2 mg of DMBA/100 gm body weight produced a tumor incidence of approximately 90 per cent in 19 weeks, in contrast to an incidence of 80 per cent in 47 weeks with a dose of 1.25 mg. The rats which received the higher dose of carcinogen had twice as many tumors per rat as the others.

The simultaneous administration of 0.6 mg. of estradiol caused an earlier appearance of tumors, increased the tumor incidence to 100 per cent in about 16 weeks, increased the number of tumors per rat, and yielded mammary adenocarcinomas almost exclusively. Six-tenths milligram of diethylstilbestrol was almost as effective as estradiol. Neither hormone alone in doses up to 4 mg/100 gm body weight produced any tumors.

* Supported in part by grants-in-aid from the National Cancer Institute, National Institutes of Health, United States Public Health Service, Bethesda, Md.; from the American Cancer Society through an institutional grant to Harvard University; and from The Nutrition Foundation, Inc., N.Y.

Received 1/31/53.


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Woditschka, J. D. Haag, J. L. Waller, D. M. Monson, A. A. Hitt, H. L. Brose, R. Hu, Y. Zheng, P. A. Watson, K. Kim, et al.
Neu-Induced Retroviral Rat Mammary Carcinogenesis: A Novel Chemoprevention Model for Both Hormonally Responsive and Nonresponsive Mammary Carcinomas.
Cancer Res., July 1, 2006; 66(13): 6884 - 6891.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
C. Huggins
Endocrine-Induced Regression of Cancers
Science, May 26, 1967; 156(3778): 1050 - 1054.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1953 by the American Association for Cancer Research.